Actinium Pharmaceuticals (ATNM) EBIT Margin (2018 - 2026)
Actinium Pharmaceuticals' EBIT Margin was 78.76% in Q2 2026.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) EBIT Margin (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Actinium Pharmaceuticals' EBIT Margin was 26.53% through Jun 30, 2026; for FY2025, it came in at -40274.44%.
- EBIT Margin shows a five-year change of -27694.11 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -64098.77% in FY2023 (-60787.70 pp), -3311.07% in FY2022 (-1128.90 pp) and -2182.17% in FY2021 (+10398.17 pp).
- The Q2 2026 figure marks the highest quarterly EBIT Margin in data going back to Q1 2018.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2023 (a gain of 20440.58 percentage points); the worst was Q4 2021 (a drop of 23291.30 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - | 78.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.76% |
| Mar 31, 2026 | -1,549.34% |
| Sep 30, 2025 | -6,324.44% |
| Jun 30, 2025 | -1,200.48% |
| Mar 31, 2025 | -2,376.86% |
| Sep 30, 2024 | -1,219.85% |
| Jun 30, 2024 | -1,166.01% |
| Mar 31, 2024 | -1,035.28% |
| Dec 31, 2023 | -1,015.01% |
| Sep 30, 2023 | -1,334.98% |
| Jun 30, 2023 | -3,393.06% |
| Mar 31, 2023 | -2,117.73% |
| Sep 30, 2022 | -21,775.56% |
| Jun 30, 2022 | -17,444.44% |
| Mar 31, 2022 | -549.36% |
| Dec 31, 2021 | -34,991.30% |
| Sep 30, 2021 | -2,776.39% |
| Jun 30, 2021 | -1,907.89% |
| Mar 31, 2021 | -863.67% |
| Dec 31, 2020 | -11,700.00% |
API Access
Actinium Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();